Valant Behavioral Health EHR
Focus your efforts on providing exceptional, data-driven care with Valant, the all-in-one EHR and practice management software designed exclusively for behavioral health practices of all sizes. Valant is built to help you spend less time on administrative tasks and more time providing quality care to individuals and groups.
Speed your process when you:
- Reduce documentation stress with a system that generates clinical narratives - practically completing your notes for you.
- Schedule 80+ built-in, reportable outcome measures to automatically send to patients before appointments through the MYIO Patient Portal.
- Have the system generate a coded charge when you record appointments.
- Automate your patient onboarding process and have intake packets waiting for patients to sign within their portal.
- Receive requests for services directly in your EHR, manage new patient inquiries, and get a data-driven match score with new patients.
Learn more
RXNT
RXNT's cloud-based, ambulatory healthcare software empowers medical practices and healthcare organizations of all sizes and most specialties to launch, succeed, and scale through innovative, data-backed, AI-powered software.
Our integrated, ONC-certified healthcare software system—including Electronic Health Records, Practice Management, Medical Billing and RCM, E-Prescribing, Practice Scheduling, Patient Portal, and more—will streamline clinical outcomes, practice management, and revenue cycle management for your medical organization.
RXNT is trusted by over 60 thousand providers and medical professionals across all 50 states in the U.S.A. to drive business growth, optimize operations, and improve the quality of patient care.
All of our SaaS-based software products can be purchased standalone, but you can run you entire practice—from encounter to billing—with our unified Full Suite system. It utilizes a secure, central database so your data passes through every product in real-time from anywhere. Using our software, more than 125MM prescriptions have been transmitted and over $7B in claims have been processed.
Our predictable, transparent subscription pricing model includes free setup & training, support, mobile apps, and more.
Learn more
SYNCRASY
Our innovative data-driven approach, combined with the expertise of our talented team and the strength of our products, drives the transformation of advanced Value-Based Care technology. We hold the conviction that healthcare is an invaluable resource, and everyone deserves to maximize the benefits of their healthcare experience. This involves stratifying and identifying patient needs, coordinating care efficiently, and actively engaging members throughout their healthcare journey. We also focus on generic drug equivalency, pricing strategies, and providing educational materials for patients. In addition, we manage referrals, encounters or claims, eligibility, enrollment, and member reward programs. Comprehensive analytics, detailed reports, enhanced patient engagement, and seamless EHR integration are also key components of our approach to healthcare improvement. Ultimately, our mission is to ensure that every interaction and service is tailored to enhance health outcomes for individuals.
Learn more
Genomenon
Pharmaceutical companies require extensive genomic data to effectively implement precision medicine initiatives; however, they frequently rely on merely 10% of the available information for their decisions. Genomenon provides access to the complete dataset. Their Prodigy™ Patient Landscapes offer a streamlined and economical solution for natural history research, aiding the creation of therapies for rare diseases by deepening understanding of both retrospective and prospective health data. Utilizing an advanced AI-driven methodology, Genomenon conducts a thorough evaluation of each patient documented in the medical literature in a significantly reduced timeframe. Ensure you capture all relevant insights by exploring every genomic biomarker featured in published studies. Each scientific claim is substantiated by concrete evidence drawn from the medical literature, allowing researchers to uncover all genetic drivers and identify variants recognized as pathogenic in accordance with ACMG clinical standards, thereby enhancing the development process of targeted therapies. By leveraging this comprehensive approach, pharma companies can enhance their research effectiveness and ultimately improve patient outcomes.
Learn more